Ernst van den Ende over CRISPR-Cas: 'De GMO-richtlijn moet worden aangepast'

Nieuws

Ernst van den Ende on CRISPR-Cas: 'The GMO directive needs to be amended'

Gepubliceerd op
25 maart 2019

In the latest issue of Wageningen World, Wageningen Plant Research director Ernst van den Ende discusses the future of CRISPR-Cas. Last year, the European Court of Justice ruled that plant breeding using CRISPR-Cas constitutes genetic modification. Van den Ende now gives his thoughts on the consequences of that decision: 'The European directive is no longer appropriate for modern-day technology.'